Association of personalized and tumor-informed ctDNA with patient survival outcomes in pancreatic adenocarcinoma

RT @plainyogurt21: I cannot emphasize this enough. You should be treating MRD+ if anything is available. here's Open Evidence, nitpick th…

RT @plainyogurt21: I cannot emphasize this enough. You should be treating MRD+ if anything is available. here's Open Evidence, nitpick th…

RT @plainyogurt21: I cannot emphasize this enough. You should be treating MRD+ if anything is available. here's Open Evidence, nitpick th…

And for those opponents of cancer screening, eventually history will prove you all to be luddites. https://t.co/R5PO2i93w8